Cargando…
Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China
BACKGROUND: Although the introduction of antiretroviral therapy (ART) decreased the mortality of people living with Human Immunodeficiency Virus (PLHIV), substantially, hundreds of thousands of people are dying of AIDS each year. The accurate survival patterns and factors related to death among PLHI...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627204/ https://www.ncbi.nlm.nih.gov/pubmed/36339239 http://dx.doi.org/10.3389/fpubh.2022.989127 |
_version_ | 1784822913258487808 |
---|---|
author | Zhu, Zhengping Xu, Yuanyuan Wu, Sushu Li, Xin Shi, Hongjie Dong, Xiaoxiao Xu, Wenjiong |
author_facet | Zhu, Zhengping Xu, Yuanyuan Wu, Sushu Li, Xin Shi, Hongjie Dong, Xiaoxiao Xu, Wenjiong |
author_sort | Zhu, Zhengping |
collection | PubMed |
description | BACKGROUND: Although the introduction of antiretroviral therapy (ART) decreased the mortality of people living with Human Immunodeficiency Virus (PLHIV), substantially, hundreds of thousands of people are dying of AIDS each year. The accurate survival patterns and factors related to death among PLHIV were rarely reported. In this study, we evaluated survival status and identified factors associated with death among PLHIV in Nanjing. METHODS: We conducted a retrospective analysis of PLHIV followed-up in Nanjing and registered to the national HIV/AIDS comprehensive management information system from 2005 to 2018. We used the life table to calculate the cumulative survival rates. We applied the Kaplan-Meier to calculate median survival times and employed cox hazard proportional regression to analyze the associated factors related to death. RESULTS: The median survival time of PLHIV was 11.8 (95%CI:11.6–11.9) years from 2005 to 2018. Among 4,235 PLHIV included in this study, 7.5% had died of AIDS-related disease and the AIDS-related mortality rate was 2.0/100 PYs. The cumulative proportion surviving at the end of the interval was 95.2% over the 1st year, 94.0% over the 2nd year, 91.8% over the 5th year, and 85.4% over the 10th year, respectively. PLHIV who unaccepted ART showed a greater risk of death compared to those who accepted ART (AHR = 16.2, 95%CI:11.9~22.2). For baseline CD4 count, compared to CD4 < 200 cell/μL, higher CD4 count was demonstrated as a protective factor, with AHR = 0.2 (95%CI: 0.1~0.3) for ≥500 cell/μL, AHR = 0.3 (95%CI:0.2~0.4) for 350~499 cell/μL, AHR = 0.4 (95%CI:0.3~0.6 for 200~349 cell/μL). In addition, we observed a higher death risk in PLHIV who were screened through outpatient (AHR = 1.6, 95%CI: 1.1~2.2) and inpatient (AHR = 1.6, 95%CI: 1.1~2.5) compared to through VCT; the age of diagnosis was ≥50 years old (AHR = 9.5, 95%CI: 3.7~24.1) and 25~49 years old (AHR = 5.0, 95%CI: 2.0~12.3) compared to ≤ 24 years old; educated from junior and below (AHR = 3.4, 95%CI: 2.3~5.1) and Senior high school (AHR = 1.7, 95%CI: 1.1~2.7) compared to college and above. CONCLUSION: The AIDS-related mortality among PLHIV in Nanjing was relatively low. A higher risk for AIDS-related deaths were observed among PLHIV who unaccepted ART, whose baseline CD4 cell count was<200 cell/μL, older age, and lower educated. |
format | Online Article Text |
id | pubmed-9627204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96272042022-11-03 Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China Zhu, Zhengping Xu, Yuanyuan Wu, Sushu Li, Xin Shi, Hongjie Dong, Xiaoxiao Xu, Wenjiong Front Public Health Public Health BACKGROUND: Although the introduction of antiretroviral therapy (ART) decreased the mortality of people living with Human Immunodeficiency Virus (PLHIV), substantially, hundreds of thousands of people are dying of AIDS each year. The accurate survival patterns and factors related to death among PLHIV were rarely reported. In this study, we evaluated survival status and identified factors associated with death among PLHIV in Nanjing. METHODS: We conducted a retrospective analysis of PLHIV followed-up in Nanjing and registered to the national HIV/AIDS comprehensive management information system from 2005 to 2018. We used the life table to calculate the cumulative survival rates. We applied the Kaplan-Meier to calculate median survival times and employed cox hazard proportional regression to analyze the associated factors related to death. RESULTS: The median survival time of PLHIV was 11.8 (95%CI:11.6–11.9) years from 2005 to 2018. Among 4,235 PLHIV included in this study, 7.5% had died of AIDS-related disease and the AIDS-related mortality rate was 2.0/100 PYs. The cumulative proportion surviving at the end of the interval was 95.2% over the 1st year, 94.0% over the 2nd year, 91.8% over the 5th year, and 85.4% over the 10th year, respectively. PLHIV who unaccepted ART showed a greater risk of death compared to those who accepted ART (AHR = 16.2, 95%CI:11.9~22.2). For baseline CD4 count, compared to CD4 < 200 cell/μL, higher CD4 count was demonstrated as a protective factor, with AHR = 0.2 (95%CI: 0.1~0.3) for ≥500 cell/μL, AHR = 0.3 (95%CI:0.2~0.4) for 350~499 cell/μL, AHR = 0.4 (95%CI:0.3~0.6 for 200~349 cell/μL). In addition, we observed a higher death risk in PLHIV who were screened through outpatient (AHR = 1.6, 95%CI: 1.1~2.2) and inpatient (AHR = 1.6, 95%CI: 1.1~2.5) compared to through VCT; the age of diagnosis was ≥50 years old (AHR = 9.5, 95%CI: 3.7~24.1) and 25~49 years old (AHR = 5.0, 95%CI: 2.0~12.3) compared to ≤ 24 years old; educated from junior and below (AHR = 3.4, 95%CI: 2.3~5.1) and Senior high school (AHR = 1.7, 95%CI: 1.1~2.7) compared to college and above. CONCLUSION: The AIDS-related mortality among PLHIV in Nanjing was relatively low. A higher risk for AIDS-related deaths were observed among PLHIV who unaccepted ART, whose baseline CD4 cell count was<200 cell/μL, older age, and lower educated. Frontiers Media S.A. 2022-10-19 /pmc/articles/PMC9627204/ /pubmed/36339239 http://dx.doi.org/10.3389/fpubh.2022.989127 Text en Copyright © 2022 Zhu, Xu, Wu, Li, Shi, Dong and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Zhu, Zhengping Xu, Yuanyuan Wu, Sushu Li, Xin Shi, Hongjie Dong, Xiaoxiao Xu, Wenjiong Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China |
title | Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China |
title_full | Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China |
title_fullStr | Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China |
title_full_unstemmed | Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China |
title_short | Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China |
title_sort | survival and risk factors associated with mortality in people living with hiv from 2005 to 2018 in nanjing, china |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627204/ https://www.ncbi.nlm.nih.gov/pubmed/36339239 http://dx.doi.org/10.3389/fpubh.2022.989127 |
work_keys_str_mv | AT zhuzhengping survivalandriskfactorsassociatedwithmortalityinpeoplelivingwithhivfrom2005to2018innanjingchina AT xuyuanyuan survivalandriskfactorsassociatedwithmortalityinpeoplelivingwithhivfrom2005to2018innanjingchina AT wusushu survivalandriskfactorsassociatedwithmortalityinpeoplelivingwithhivfrom2005to2018innanjingchina AT lixin survivalandriskfactorsassociatedwithmortalityinpeoplelivingwithhivfrom2005to2018innanjingchina AT shihongjie survivalandriskfactorsassociatedwithmortalityinpeoplelivingwithhivfrom2005to2018innanjingchina AT dongxiaoxiao survivalandriskfactorsassociatedwithmortalityinpeoplelivingwithhivfrom2005to2018innanjingchina AT xuwenjiong survivalandriskfactorsassociatedwithmortalityinpeoplelivingwithhivfrom2005to2018innanjingchina |